David Apelian

David Apelian

Director Ejecutivo en
Theolytics Ltd.
.
61 años
Health Technology
Consumer Services

Perfil

David Apelian is currently Chief Executive Officer at Theolytics Ltd. since 2024.
Formerly, Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. from 2022 to 2024, Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013, Clinical Director-Infectious Diseases Group at Bristol Myers Squibb Co. from 2002 to 2004, Clinical Director-Hepatology Department at Schering-Plough Corp.
USA from 1999 to 2002, and Vice President at Wyeth Pharmaceuticals LLC.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA from Quinnipiac University.

Cargos activos de David Apelian

EmpresasCargoInicio
Director Ejecutivo 17/12/2024

Antiguos cargos conocidos de David Apelian.

EmpresasCargoFin
EIGER BIOPHARMACEUTICALS Director Ejecutivo 01/09/2024
Director Ejecutivo 04/10/2022
ACHILLION PHARMACEUTICALS, INC. Director Técnico/Científico/I+D 28/12/2017
GLOBEIMMUNE, INC. Director Técnico/Científico/I+D 01/01/2013
BRISTOL-MYERS SQUIBB COMPANY Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de David Apelian.

Formación de David Apelian.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

54

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology